XLO CIK: 1840233

Xilio Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−80.8
FY22:
−75.7
FY23:
−68.6
FY24:
−18.4
FY25:
−4.99
Change from FY21 to FY25
millions USD
FY21:
−1.10
FY22:
−1.87
FY23:
−0.49
FY24:
−0.04
FY25:
−0.52
Change from FY21 to FY25
millions USD
FY21:
261
FY22:
−0.07
FY23:
−6.55
FY24:
29.2
FY25:
87.8
millions USD
FY21:
179
FY22:
−77.7
FY23:
−75.7
FY24:
10.8
FY25:
82.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−81.9
FY22:
−77.6
FY23:
−69.1
FY24:
−18.4
FY25:
−5.51

All amounts in millions USD Data source:SEC EDGAR